Ghrelin and Motilin in the gastrointestinal system

Current Pharmaceutical Design

Volumn 18, Issue 31, 2012, Pages 4755-4765

  Chen, Chih Yen ^a,b   Tsai, Chang Youh ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Adiposity; Anorexia; Appetite; Cachexia; Gastrointestinal; Ghrelin; Ileus; Inflammation; Motilin; Motility

Indexed keywords

1 ACETOXYMETHYL 3 [7 [[1 (N,N DIMETHYLCARBAMOYL) 6 (4 FLUOROPHENYL) 3 INDOLYL]CARBONYL] 1H,3H PYRROLO[1,2 C]THIAZOL 3 YL]PYRIDINIUM CHLORIDE; ACYL GHRELIN; ALEMCINAL; CISPLATIN; DES ACYL GHRELIN; ERYTHROMYCIN; FENFLURAMINE; FLUVOXAMINE; GHRELIN; HERBACEOUS AGENT; MITEMCINAL; MOTILIN; RIKKUNSHITO; SEROTONIN AGONIST; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON MOTILITY; DIABETES MELLITUS; ESOPHAGUS MOTILITY; GASTROINTESTINAL CARCINOMA; GASTROINTESTINAL MOTILITY; HUMAN; HUNGER; INFLAMMATION; INTESTINE MOTILITY; NEUROENDOCRINE TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH MUCOSA INJURY; STOMACH PROTECTION; STOMACH SECRETION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; DRUGS, CHINESE HERBAL; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; GHRELIN; HUMANS; JAPAN; MEDICINE, TRADITIONAL; MOTILIN; ORGAN SPECIFICITY;

EID: 84861646378     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212803216915     Document Type: Article

References (158)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
2. Hosoda H, Kojima M, Matsuo H, Kangawa K. Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem 2000; 275: 21995-22000.
3. Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996; 273: 974-977.
4. Guan XM, Yu H, Palyha OC, et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 1997; 48: 23-29.
5. Wettschureck N, Moers A, Wallenwein B, Parlow AF, Maser-Gluth C, Offermanns S. Loss of Gq/11 family G proteins in the nervous system causes pituitary somatotroph hypoplasia and dwarfism in mice. Mol Cell Biol 2005; 25: 1942-1948.
6. Chen CY, Tsai CY, Lee WJ, et al. Intracerebroventricular O-noctanoylated ghrelin and its splice variant-induced feeding is blocked by insulin, independent of obestatin or CRF receptor, in satiated rats. Nutrition 2012; 28: 812-820.
7. Broglio F, Gottero C, Prodam F, et al. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 2004; 89: 3062-3065.
8. Garcia JM, Garcia-Touza M, Hijazi RA, et al. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab 2005; 90: 2920-2926.
9. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and desacyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 2000; 279: 909-913.
10. Yoshimoto A, Mori K, Sugawara A, et al. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 2002; 13: 2748-2752.
11. Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310: 996-999.
12. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetitestimulating peptide hormone. Cell 2008; 132: 387-396.
13. Gutierrez JA, Solenberg PJ, Perkins DR, et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 2008; 105: 6320-6325.
14. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714-1719.
15. Tschöp M, Wawarta R, Riepl RL, et al. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 2001; 24: RC19-RC21.
16. Lee WJ, Chen CY, Chong K, Lee YC, Chen SC, Lee SD. Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis 2011; 7: 683-690.
17. Diniz Mde F, Azeredo Passos VM, Diniz MT. Bariatric surgery and the gut-brain communication--the state of the art three years later. Nutrition 2010; 26: 925-931.
18. Chen CY, Asakawa A, Fujimiya M, Lee SD, Inui A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev 2009; 61: 430-481.
19. Chen CY, Fujimiya M, Asakawa A, et al. At the cutting edge: ghrelin gene products in food intake and gut motility. Neuroendocrinology 2009; 89: 9-17.
20. Mitznegg P, Bloom SR, Domschke W, Domschke S, Wunsch E, Demling L. Release of motilin after duodenal acidification. Lancet 1976; 1(7965): 888-889.
21. Peeters T, Matthijs G, Depoortere I, Cachet T, Hoogmartens J, Vantrappen G. Erythromycin is a motilin receptor agonist. Am J Physiol 1989; 257: G470-G474.
22. Samson WK, Lumpkin MD, McCann SM. Motilin: a novel growth hormone releasing agent. Brain Res Bull 1982; 8: 117-21.
23. Samson WK, Lumpkin MD, Nilaver G, McCann SM. Motilin stimulates growth hormone release in vitro. Brain Res Bull 1984; 12: 57-62.
24. Itoh Z. Motilin and clinical application. Peptides 1997; 18: 593-608.
25. Ohno T, Mochiki E, Kuwano H. The roles of motilin and ghrelin in gastrointestinal motility. Int J Pept 2010; 2010. pii: 820794.
26. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone- releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255-4261.
27. Ueberberg B, Unger N, Saeger W, Mann K, Petersenn S. Expression of ghrelin and its receptor in human tissues. Horm Metab Res 2009; 41: 814-821.
28. Tanaka-Shintani M, Watanabe M. Distribution of ghrelinimmunoreactive cells in human gastric mucosa: comparison with that of parietal cells. J Gastroenterol 2005; 40: 345-349.
29. Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87: 2988-2991.
30. Lim CT, Kola B, Grossman A, Korbonits M. The expression of ghrelin O-acyltransferase (GOAT) in human tissues. Endocr J 2011; 58: 707-710.
31. He J, Irwin DM, Chen R, Zhang YP. Stepwise loss of motilin and its specific receptor genes in rodents. J Mol Endocrinol 2010; 44: 37-44.
32. Guo F, Xu L, Sun X, Gao S, Zhu H. The paraventricular nucleus modulates thyroidal motilin release and rat gastric motility. J Neuroendocrinol 2011; 23: 767-777.
33. Asakawa A, Inui A, Kaga T, et al. Ghrelin is an appetitestimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001; 120: 337-345.
34. Tomasetto C, Karam SM, Ribieras S, et al. Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology 2000; 119: 395-405.
35. Kitazawa T, Kaiya H, Taneike T. Contractile effects of ghrelinrelated peptides on the chicken gastrointestinal tract in vitro. Peptides 2007; 28: 617-624.
36. Chen CY, Huang SC. Lack of direct effects of acyl ghrelin, desacyl ghrelin, and obestatin on rat lower esophageal sphincter motility in vitro. J Chin Med Assoc 2011; 74: 394-399.
37. Marzio L, Grossi L, Martelli L, Falcucci M, Lapenna D. Migrating motor complex recorded spontaneously and induced by motilin and erythromycin in an ex vivo rabbit intestinal preparation. Peptides 1994; 15: 1067-1077.
38. Kohjitani A, Shirakawa J, Okada S, Obara H. Effects of various peptides on isolated rabbit lower esophageal sphincter. Peptides 1996; 17: 927-931.
39. Jennewein HM, Hummelt H, Siewert R, Waldeck F. The motorstimulating effect of natural motilin on the lower esophageal sphincter fundus, antrum and duodenum in dogs. Digestion 1975; 13: 246-250.
40. Itoh Z, Aizawa I, Honda R, Hiwatashi K, Couch EF. Control of lower-esophageal-sphincter contractile activity by motilin in conscious dogs. Am J Dig Dis 1978; 23: 341-345.
41. Chaussade S, Michopoulos S, Sogni P, Guerre J, Couturier D. Motilin agonist erythromycin increases human lower esophageal sphincter pressure by stimulation of cholinergic nerves. Dig Dis Sci 1994; 39: 381-384.
42. Koutsoumbi P, Epanomeritakis E, Tsiaoussis J, et al. The effect of erythromycin on human esophageal motility is mediated by serotonin receptors. Am J Gastroenterol 2000; 95: 3388-3392.
43. Domschke W, Lux G, Mitznegg P, et al. Relationship of plasma motilin response to lower esophageal sphincter pressure in man. Scand J Gastroenterol (Suppl.) 1976; 39: 81-84.
44. Champion G, Richter JE, Singh S, Schan C, Nellans H. Effects of oral erythromycin on esophageal pH and pressure profiles in patients with gastroesophageal reflux disease. Dig Dis Sci 1994; 39: 129-137.
45. van Herwaarden MA, Samsom M, van Nispen CH, Verlinden M, Smout AJ. The effect of motilin agonist ABT-229 on gastro oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. Aliment Pharmacol Ther 2000; 14: 453-462.
46. Altraif I, Handoo FA, Aljumah A, et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double-blind, placebo-controlled trial. Gastrointest Endosc 2011; 73: 245-250.
47. Sanger GJ, Hellström PM, Näslund E. The hungry stomach: physiology, disease, and drug development opportunities. Front Pharmacol 2010; 1: 145.
48. Ariga H, Tsukamoto K, Chen C, Mantyh C, Pappas TN, Takahashi T. Endogenous acyl ghrelin is involved in mediating spontaneous phase III-like contractions of the rat stomach. Neurogastroenterol Motil 2007; 19: 675-680.
49. Yin J, Chen J. Inhibitory effects of gastric electrical stimulation on ghrelin-induced excitatory effects on gastric motility and food intake in dogs. Scand J Gastroenterol 2006; 41: 903-909.
50. Fujino K, Inui A, Asakawa A, Kihara N, Fujimura M, Fujimiya M. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol 2003; 550: 227-240.
51. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 2006; 55: 327-333.
52. Kitazawa T, De Smet B, Verbeke K, Depoortere I, Peeters TL. Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro. Gut 2005; 54: 1078-1084.
53. de Winter BY, de Man JG, Seerden TC, et al. Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice. Neurogastroenterol Motil 2004; 16: 439-446.
54. Dornonville de la Cour C, Lindstrom E, Norlen P, Hakanson R. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul Pept 2004; 120: 23-32.
55. Trudel L, Tomasetto C, Rio MC, et al. Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol Gastrointest Liver Physiol 2002; 282: G948-G952.
56. Fukuda H, Mizuta Y, Isomoto H, et al. Ghrelin enhances gastric motility through direct stimulation of intrinsic neural pathways and capsaicin-sensitive afferent neurones in rats. Scand J Gastroenterol 2004; 39: 1209-1214.
57. Chen CY, Inui A, Asakawa A, et al. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 2005; 129: 8-25.
58. Depoortere I, de Winter B, Thijs T, de Man J, Pelckmans P, Peeters T. Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro. Eur J Pharmacol 2005; 515: 160-168.
59. Levin F, Edholm T, Ehrstrom M, et al. Effect of peripherally administered ghrelin on gastric emptying and acid secretion in the rat. Regul Pept 2005; 131: 59-65.
60. Chen CY, Doong ML, Chien EJ, et al. Intracerebroventricular ghrelin enhances non-nutrient semiliquid gastric emptying in fasted conscious rats. Gastroenterol J Taiwan 2008; 25: 242-248.
61. Ariga H, Nakade Y, Tsukamoto K, et al. Ghrelin accelerates gastric emptying via early manifestation of antro-pyloric coordination in conscious rats. Regul Pept 2008; 146: 112-116.
62. Levin F, Edholm T, Schmidt PT, et al. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab 2006; 91: 3296-3302.
63. Falkén Y, Hellström PM, Sanger GJ, et al. Actions of prolonged ghrelin infusion on gastrointestinal transit and glucose homeostasis in humans. Neurogastroenterol Motil 2010; 22: e192-e200.
64. Ohno T, Kamiyama Y, Aihara R, et al. Ghrelin does not stimulate gastrointestinal motility and gastric emptying: an experimental study of conscious dogs. Neurogastroenterol Motil 2006; 18: 129-135.
65. Ataka K, Inui A, Asakawa A, Kato I, Fujimiya M. Obestatin inhibits motor activity in the antrum and duodenum in the fed state of conscious rats. Am J Physiol Gastrointest Liver Physiol 2008; 294: G1210-G1218.
66. Itoh Z, Honda R, Hiwatashi K, et al. Motilin induced mechanical activity in the canine alimentary tract. Scand J Gastroenterol 1976; 11(suppl 39): 93-110.
67. Lee KY, Chang TM, Chey WY. Effect of rabbit antimotilin serum on myoelectric activity and plasma motilin concentration in fasting dog. Am J Physiol 1983; 245: G547-G553.
68. Itoh Z, Mizumoto A, Iwanaga Y, Yoshida N, Torii K, Wakabayashi K. Involvement of 5-hydroxytryptamine 3 receptors in regulation of interdigestive gastric contractions by motilin in the dog. Gastroenterology 1991; 100: 901-908.
69. Christofides ND, Modlin IM, Fitzpatrick ML, Bloom SR. Effect of motilin on the rate of gastric emptying and gut hormone release during breakfast. Gastroenterology 1979; 76: 903-907.
70. Christofides ND, Long RG, Fitzpatrick ML, McGregor GP, Bloom SR. Effect of motilin on the gastric emptying of glucose and fat in humans. Gastroenterology 1981; 80: 456-460.
71. Yogo K, Onoma M, Ozaki K, Koto M, Itoh Z, Omura S, Takanashi H. Effects of oral mitemcinal (GM-611), erythromycin, EM-574 and cisapride on gastric emptying in conscious rhesus monkeys. Dig Dis Sci 2008; 53: 912-918.
72. Yokoyama T, Kitazawa T, Takasaki K, Ishii A, Karasawa A. Recovery of gastrointestinal motility from post-operative ileus in dogs: effects of Leu13-motilin (KW-5139) and prostaglandin F2 alpha. Neurogastroenterol Motil 1995; 7: 199-210.
73. Chen CY, Fujimiya M, Laviano A, Chang FY, Lin HC, Lee SD. Modulation of ingestive behavior and gastrointestinal motility by ghrelin in diabetic animals and humans. J Chin Med Assoc 2010; 73: 225-229.
74. El-Salhy M, Rauma J. Low density of ghrelin cells in the oxyntic mucosa correlated to slow gastric emptying in patients with type 1 diabetes. Mol Med Report 2009; 2: 893-896.
75. Charoenthongtrakul S, Giuliana D, Longo KA, et al. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists. J Pharmacol Exp Ther 2009; 329: 1178-1186.
76. Ejskjaer N, Dimcevski G, Wo J, et al. Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study. Neurogastroenterol Motil 2010; 22: 1069-e1281.
77. Wo JM, Ejskjaer N, Hellström PM, et al. Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting--randomised clinical study subset data. Aliment Pharmacol Ther 2011; 33: 679-688.
78. Shindo T, Futagami S, Hiratsuka T, et al. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease. Digestion 2009; 79: 65-72.
79. Lee KJ, Cha DY, Cheon SJ, Yeo M, Cho SW. Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility-like functional dyspepsia. Digestion 2009; 80: 58-63.
80. Nakanome C, Akai H, Hongo M, et al. Disturbances of the alimentary tract motility and hypermotilinemia in the patients with diabetes mellitus. Tohoku J Exp Med 1983; 139: 205-215.
81. Pendleton H, Ekman R, Olsson R, Ekberg O, Ohlsson B. Motilin concentrations in relation to gastro intestinal dysmotility in diabetes mellitus. Eur J Intern Med 2009; 20: 654-659.
82. Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000; 276: 905-908.
83. Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K, Matsukura S. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun 2001; 280: 904-907.
84. Chen CY, Fujimiya M, Asakawa A, Lee SD, Inui A. Regulation of ingestive behavior, the upper gastrointestinal motility and gastric acid secretion by ghrelin in mammals. Curr Nutr Food Sci 2008; 4: 32-40.
85. Fukumoto K, Nakahara K, Katayama T, Miyazatao M, Kangawa K, Murakami N. Synergistic action of gastrin and ghrelin on gastric acid secretion in rats. Biochem Biophys Res Commun 2008; 374: 60-63.
86. Sakurada T, Ro S, Onouchi T, et al. Comparison of the actions of acylated and desacylated ghrelin on acid secretion in the rat stomach. J Gastroenterol 2010; 45: 1111-1120.
87. Yakabi K, Ro S, Onouhi T, et al. Histamine mediates the stimulatory action of ghrelin on acid secretion in rat stomach. Dig Dis Sci 2006; 51: 1313-1321.
88. Bilgin HM, Tumer C, Diken H, Kelle M, Sermet A. Role of ghrelin in the regulation of gastric acid secretion involving nitrergic mechanisms in rats. Physiol Res 2008; 57: 563-568.
89. Sibilia V, Pagani F, Guidobono F, et al. Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats. Neuroendocrinology 2002; 75: 92-97.
90. Sibilia V, Muccioli G, Deghenghi R, et al. Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat. J Neuroendocrinol 2006; 18: 122-128.
91. Mori M, Suzuki H, Masaoka T, et al. Intravenous ghrelin administration enhances gastric acid secretion - evaluation using wireless pH capsule. Aliment Pharmacol Ther 2006; 24 (Suppl 4): 96-103.
92. Sibilia V, Rindi G, Pagani F, et al. Ghrelin protects against ethanolinduced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology 2003; 144: 353-359.
93. Ceranowicz P, Warzecha Z, Dembinski A, et al. Treatment with ghrelin accelerates the healing of acetic acid-induced gastric and duodenal ulcers in rats. J Physiol Pharmacol 2009; 60: 87-98.
94. Brzozowski T, Konturek PC, Konturek SJ, et al. Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regul Pept 2004; 120: 39-51.
95. Brzozowski T, Konturek PC, Sliwowski Z, et al. Prostaglandin/cyclooxygenase pathway in ghrelin-induced gastroprotection against ischemia-reperfusion injury. J Pharmacol Exp Ther 2006; 319: 477-487.
96. Konturek PC, Brzozowski T, Pajdo R, et al. Ghrelin-a new gastroprotective factor in gastric mucosa. J Physiol Pharmacol 2004; 55: 325-336.
97. Konturek PC, Brzozowski T, Walter B, Burnat G, Hess T, Hahn EG, Konturek SJ. Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide. Eur J Pharmacol 2006; 536: 171-181.
98. Adami M, Pozzoli C, Leurs R, Stark H, Coruzzi G. Histamine H(3) receptors are involved in the protective effect of ghrelin against HCl-induced gastric damage in rats. Pharmacology 2010; 86: 259-266.
99. Edholm T, Levin F, Hellström PM, Schmidt PT. Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons. Regul Pept 2004; 121: 25-30.
100. Chen CY, Chao Y, Chang FY, Chien EJ, Lee SD, Doong ML. Intracisternal des-acyl ghrelin inhibits food intake and non-nutrient gastric emptying in conscious rats. Int J Mol Med 2005; 16: 695-699.
101. Janssens J, Vantrappen G, Peeters TL. The activity front of the migrating motor complex of the human stomach but not of the small intestine is motilin-dependent. Regul Pept 1983; 6: 363-369.
102. Luiking YC, Akkermans LM, van der Reijden AC, Peeters TL, van Berge-Henegouwen GP. Differential effects of motilin on interdigestive motility of the human gastric antrum, pylorus, small intestine and gallbladder. Neurogastroenterol Motil 2003; 15: 103-111.
103. Tebbe JJ, Tebbe CG, Mronga S, Ritter M, Schäfer MK. Central neuropeptide Y receptors are involved in 3rd ventricular ghrelin induced alteration of colonic transit time in conscious fed rats. BMC Gastroenterol 2005; 5: 5.
104. Shimizu Y, Chang EC, Shafton AD, et al. Evidence that stimulation of ghrelin receptors in the spinal cord initiates propulsive activity in the colon of the rat. J Physiol 2006; 576: 329-338.
105. Shafton AD, Sanger GJ, Witherington J, et al. Oral administration of a centrally acting ghrelin receptor agonist to conscious rats triggers defecation. Neurogastroenterol Motil 2009; 21: 71-77.
106. Chen CY, Doong ML, Li CP, et al. A novel simultaneous measurement method to assess the influence of intracerebroventricular obestatin on colonic motility and secretion in conscious rats. Peptides 2010; 31: 1113-1117.
107. Chen CY, Chien EJ, Chang FY, Lu CL, Luo JC, Lee SD. Impacts of peripheral obestatin on colonic motility and secretion in conscious fed rats. Peptides 2008; 29: 1603-1608.
108. Miller P, Trudel L, St-Pierre S, Takanashi H, Poitras P. Neural and muscular receptors for motilin in the rabbit colon. Peptides 2000; 21: 283-287.
109. Kitazawa T, Ichikawa S, Yokoyama T, Ishii A, Shuto K. Stimulating action of KW-5139 (Leu13-motilin) on gastrointestinal motility in the rabbit. Br J Pharmacol 1994; 111: 288-294.
110. Hasler WL, Heldsinger A, Chung OY. Erythromycin contracts rabbit colon myocytes via occupation of motilin receptors. Am J Physiol 1992; 262: G50-G55.
111. Bickel M, Belz U. Motilin and a synthetic enkephalin induce colonic motor complexes (CMC) in the conscious dog. Peptides 1988; 9: 501-507.
112. Ozaki K, Sudo H, Muramatsu H, et al. Mitemcinal (GM-611), an orally active motilin receptor agonist, accelerates colonic motility and bowel movement in conscious dogs. Inflammopharmacology 2007; 15: 36-42.
113. Venkova K, Thomas H, Fraser GL, Greenwood-Van Meerveld B. Effect of TZP-201, a novel motilin receptor antagonist, in the colon of the musk shrew (Suncus murinus). J Pharm Pharmacol 2009; 61: 367-373.
114. van Assche G, Depoortere I, Thijs T, et al. Contractile effects and intracellular Ca2+ signalling induced by motilin and erythromycin in the circular smooth muscle of human colon. Neurogastroenterol Motil 2001; 13: 27-35.
115. Jameson JS, Rogers J, Misiewicz JJ, Raimundo AH, Henry MM. Oral or intravenous erythromycin has no effect on human distal colonic motility. Aliment Pharmacol Ther 1992; 6: 589-595.
116. Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 100-105.
117. Tóth G, Rauh M, Nyul Z, Sulyok E, Rascher W. Serum ghrelin, adipokine and insulin levels in children with acute hepatitis. Eur J Gastroenterol Hepatol 2009; 21: 739-743.
118. Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 2006; 130: 1707-1720.
119. Konturek PC, Brzozowski T, Engel M, et al. Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves. J Physiol Pharmacol 2009; 60: 41-47.
120. Moreno M, Chaves JF, Sancho-Bru P, et al. Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans. Hepatology 2010; 51: 974-985.
121. Waseem T, Duxbury M, Ito H, Ashley SW, Robinson MK. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery 2008; 143: 334-342.
122. Yada T, Kaiya H, Mutoh K, Azuma T, Hyodo S, Kangawa K. Ghrelin stimulates phagocytosis and superoxide production in fish leukocytes. J Endocrinol 2006; 189: 57-65.
123. Chorny A, Anderson P, Gonzalez-Rey E, Delgado M. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J Immunol 2008; 180: 8369-8377.
124. Gonzalez-Rey E, Chorny A, del Moral RG, Varela N, Delgado M. Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses. Ann Rheum Dis 2007; 66: 582-588.
125. Otero M, Nogueiras R, Lago F, Dieguez C, Gomez-Reino JJ, Gualillo O. Chronic inflammation modulates ghrelin levels in humans and rats. Rheumatology (Oxford) 2004; 43: 306-10.
126. Koca SS, Ozgen M, Aydin S, Dag S, Evren B, Isik A. Ghrelin and obestatin levels in rheumatoid arthritis. Inflammation 2008; 31: 329-335.
127. Toussirot E, Streit G, Nguyen NU, et al. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis. Metabolism 2007; 56: 1383-1389.
128. Karagiozoglou-Lampoudi T, Trachana M, Agakidis C, et al. Ghrelin levels in patients with juvenile idiopathic arthritis: relation to anti-tumor necrosis factor treatment and disease activity. Metabolism 2011; 60: 1359-1362.
129. Granado M, Priego T, Martín AI, Villanúa MA, López-Calderón A. Anti-inflammatory effect of the ghrelin agonist growth hormonereleasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab 2005; 288: E486-E492.
130. Stofkova A, Haluzik M, Zelezna B, Kiss A, Skurlova M, Lacinova Z, Jurcovicova J. Enhanced expressions of mRNA for neuropeptide Y and interleukin 1 beta in hypothalamic arcuate nuclei during adjuvant arthritis-induced anorexia in Lewis rats. Neuroimmunomodulation 2009; 16: 377-384.
131. Skurlova M, Stofkova A, Kiss A, et al. Transient anorexia, hypernociception and cognitive impairment in early adjuvant arthritis in rats. Endocr Regul 2010; 44: 165-173.
132. Al M, Ng L, Tyrrell P, Bargman J, Bradley T, Silverman E. Adipokines as novel biomarkers in paediatric systemic lupus erythematosus. Rheumatology (Oxford) 2009; 48: 497-501.
133. de Sanctis JB, Zabaleta M, Bianco NE, Garmendia JV, Rivas L. Serum adipokine levels in patients with systemic lupus erythematosus. Autoimmunity 2009; 42: 272-274.
134. Kim HA, Choi GS, Jeon JY, Yoon JM, Sung JM, Suh CH. Leptin and ghrelin in Korean systemic lupus erythematosus. Lupus 2010; 19: 170-174.
135. Ferraz-Amaro I, Arce-Franco M, Muñiz J, et al. Systemic blockade of TNF-α does not improve insulin resistance in humans. Horm Metab Res 2011; 43: 801-808.
136. Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A, et al. Antitumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis. Ann Rheum Dis 2008; 67: 1644-1646.
137. de Martel C, Haggerty TD, Corley DA, Vogelman JH, Orentreich N, Parsonnet J. Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. Am J Gastroenterol 2007; 102: 1166-1172.
138. Murphy G, Kamangar F, Dawsey SM, et al. The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas. J Natl Cancer Inst 2011; 103: 1123-1129.
139. Kuiper P, Verspaget HW, Overbeek LI, Biemond I, Lamers CB. An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach. Neth J Med 2011; 69: 14-20.
140. Papotti M, Cassoni P, Volante M, Deghenghi R, Muccioli G, Ghigo E. Ghrelin-producing endocrine tumors of the stomach and intestine. J Clin Endocrinol Metab 2001; 86: 5052-5059.
141. Volante M, Allìa E, Gugliotta P, et al. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab 2002; 87: 1300-1308.
142. Corbetta S, Peracchi M, Cappiello V, et al. Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. J Clin Endocrinol Metab 2003; 88: 3117-3120.
143. Volante M, Rosas R, Ceppi P, et al. Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth. J Pathol 2009; 218: 458-466.
144. Matsumura T, Arai M, Yonemitsu Y, et al. The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice. J Gastroenterol 2010; 45: 300-307.
145. Takeda H, Sadakane C, Hattori T, et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 2008; 134: 2004-2013.
146. Yakabi K, Sadakane C, Noguchi M, et al. Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology 2010; 151: 3773-3782.
147. Yakabi K, Kurosawa S, Tamai M, et al. Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction. Regul Pept 2010; 161: 97-105.
148. Saegusa Y, Takeda H, Muto S, et al. Decreased plasma ghrelin contributes to anorexia following novelty stress. Am J Physiol Endocrinol Metab 2011; 301: E685-E696.
149. Yakabi K, Noguchi M, Ohno S, et al. Urocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptors. Am J Physiol Endocrinol Metab 2011; 301: E72-E82.
150. Takeda H, Muto S, Hattori T, et al. Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition. Endocrinology 2010; 151: 244-252.
151. Sadakane C, Muto S, Nakagawa K, et al. 10-Gingerol, a component of rikkunshito, improves cisplatin-induced anorexia by inhibiting acylated ghrelin degradation. Biochem Biophys Res Commun 2011; 412: 506-511.
152. Fujitsuka N, Asakawa A, Hayashi M, et al. Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin. Biol Psychiatry 2009; 65: 748-759.
153. Fujitsuka N, Asakawa A, Uezono Y, et al. Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival. Transl Psychiatry 2011; 1: e23.
154. Ogawa A, Mochiki E, Yanai M, et al. Interdigestive migrating contractions are coregulated by ghrelin and motilin in conscious dogs. Am J Physiol Regul Integr Comp Physiol 2012; 302: R233-R241.
155. de Smet B, Mitselos A, Depoortere I. Motilin and ghrelin as prokinetic drug targets. Pharmacol Ther 2009; 123: 207-223.
156. Chen CY, Inui A. What kind of polyunsaturated fatty acid should we eat to stay healthy? Nutrition (2012) doi:10.1016/j.nut.2012.01.009.
157. Chen CY, Lee WJ, Chong K, Lee SD, Liao YD. Impact of intracerebroventricular obestatin on plasma acyl ghrelin, des-acyl ghrelin and nesfatin-1 levels and on gastric emptying in rats. Mol Med Rep 2012; 6: 191-196.
158. Mochiki E, Yanai M, Ohno T, Kuwano H. The effect of traditional Japanese medicine (Kampo) on gastrointestinal function. Surg Today 2010; 40: 1105-1111.